Bioheart set to buy Polish ECG firm
This article was originally published in Clinica
Executive Summary
Heart failure and cardiovascular disease specialist Bioheart is on the verge of making its first company acquisition, with the purchase of MedicAlgorithmics, a Polish firm focused on developing electrocardiogram (ECG) technology. The deal, which is expected to close within the next 60-90 days, will see Bioheart gain worldwide rights to MedicAlgorithmics’ lead product, the Pocket ECG, a real-time wireless heart monitor and diagnostic system. The CE-marked product is described by Warsaw-based MedicAlgorithmics as being similar in size to an MP3 player, and is designed to automatically analyse a patent's heart beat and wirelessly transmit the data directly to a physician for the diagnosis, monitoring and potential treatment of arrhythmias and atrial fibrillation. Financial details were not disclosed.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals